This week's note from the instructor discusses the latest interim final rule with comment (IFC) and its provisions concern vaccines, payments for new COVID-19 treatments, and more.
Q: CMS recently updated its Care Compare tool, a resource that can provide valuable insight for any patient. How can case managers ensure that their patents can access and best utilize this tool?
This week’s Medicare updates include a new interim final rule on COVID-19 vaccination and payment policies, Part II of the CY 2022 Medicare Advantage and Part D Advance Notice, a proposed rule on DMEPOS coverage policies and fee schedule methodologies, and more!
CMS’ Fourth COVID-19 Interim Final Rule with Comment Period includes additional payment for new COVID-19 treatments, price transparency requirements for COVID-19 diagnostic tests, and coverage for potential vaccines among other provisions.
The HIM department plays a critical role in the revenue cycle, but it’s often placed in a reactive position, limiting its effectiveness. Learn how to improve operations by enhancing the HIM department’s involvement across the revenue cycle.
